Alternative splicing alterations of Ca2+handling genes are associated with Ca2+signal dysregulation in myotonic dystrophy type 1 ( DM1) and type 2 ( DM2) myotubes

被引:31
|
作者
Santoro, M. [1 ]
Piacentini, R. [2 ]
Masciullo, M. [3 ,4 ]
Bianchi, M. L. E. [3 ]
Modoni, A. [3 ]
Podda, M. V. [2 ]
Ricci, E. [3 ]
Silvestri, G. [3 ]
Grassi, C. [2 ]
机构
[1] ONLUS, Fdn Don Carlo Gnocchi, Milan, Italy
[2] Univ Cattolica Sacro Cuore, Inst Human Physiol, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Dept Geriatr Neurosci & Orthoped, Ctr Neuromuscular Disorders, Rome, Italy
[4] IRCCS San Raffaele Pisana, Rome, Italy
关键词
Ca(v)1; 1; intracellular calcium signals; myotonic dystrophy; myotubes; RYR1; SERCA; 3 UNTRANSLATED REGION; SKELETAL-MUSCLE; MESSENGER-RNA; TRINUCLEOTIDE REPEAT; CALCIUM-CHANNELS; CTG REPEAT; CA2+ ENTRY; PROTEINS; TRANSCRIPTS; EXPANSION;
D O I
10.1111/nan.12076
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
AimsThe pathogenesis of myotonic dystrophy type 1 (DM1) and type 2 (DM2) has been related to the aberrant splicing of several genes, including those encoding for ryanodine receptor 1 (RYR1), sarcoplasmatic/endoplasmatic Ca2+-ATPase (SERCA) and (1S) subunit of voltage-gated Ca2+ channels (Ca(v)1.1). The aim of this study is to determine whether alterations of these genes are associated with changes in the regulation of intracellular Ca2+ homeostasis and signalling. MethodsWe analysed the expression of RYR1, SERCA and Ca(v)1.1 and the intracellular Ca2+ handling in cultured myotubes isolated from DM1, DM2 and control muscle biopsies by semiquantitative RT-PCR and confocal Ca2+ imaging respectively. Results(i) The alternative splicing of RYR1, SERCA and Ca(v)1.1 was more severely affected in DM1 than in DM2 myotubes; (ii) DM1 myotubes exhibited higher resting intracellular Ca2+ levels than DM2; (iii) the amplitude of intracellular Ca2+ transients induced by sustained membrane depolarization was higher in DM1 myotubes than in controls, whereas DM2 showed opposite behaviour; and (iv) in both DM myotubes, Ca2+ release from sarcoplasmic reticulum through RYR1 was lower than in controls. ConclusionThe aberrant splicing of RYR1, SERCA1 and Ca(v)1.1 may alter intracellular Ca2+ signalling in DM1 and DM2 myotubes. The differing dysregulation of intracellular Ca2+ handling in DM1 and DM2 may explain their distinct sarcolemmal hyperexcitabilities.
引用
收藏
页码:464 / 476
页数:13
相关论文
共 50 条
  • [21] (CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis
    Yenigun, Vildan Betul
    Sirito, Mario
    Amcheslavky, Alla
    Czernuszewicz, Tomek
    Colonques-Bellmunt, Jordi
    Garcia-Alcover, Irma
    Wojciechowska, Marzena
    Bolduc, Clare
    Chen, Zhihong
    Lopez Castel, Arturo
    Krahe, Ralf
    Bergmann, Andreas
    DISEASE MODELS & MECHANISMS, 2017, 10 (08) : 993 - 1003
  • [22] Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice
    Oana, Kosuke
    Oma, Yoko
    Suo, Satoshi
    Takahashi, Masanori P.
    Nishino, Ichizo
    Takeda, Shin'ichi
    Ishiura, Shoichi
    SCIENTIFIC REPORTS, 2013, 3
  • [23] Dysregulation of GSK3β-Target Proteins in Skin Fibroblasts of Myotonic Dystrophy Type 1 (DM1) Patients
    Grande, Valentina
    Hathazi, Denisa
    O'Connor, Emily
    Marteau, Theo
    Schara-Schmidt, Ulrike
    Hentschel, Andreas
    Gourdon, Genevieve
    Nikolenko, Nikoletta
    Lochmuller, Hanns
    Roos, Andreas
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (04) : 603 - 619
  • [24] New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2)
    Sallinen, R
    Vihola, A
    Bachinski, LL
    Huoponen, K
    Haapasalo, H
    Hackman, P
    Zhang, S
    Sirito, M
    Kalimo, H
    Meola, G
    Horelli-Kuitunen, N
    Wessman, M
    Krahe, R
    Udd, B
    NEUROMUSCULAR DISORDERS, 2004, 14 (04) : 274 - 283
  • [25] TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
    Bose, Francesca
    Renna, Laura Valentina
    Fossati, Barbara
    Arpa, Giovanni
    Labate, Valentina
    Milani, Valentina
    Botta, Annalisa
    Micaglio, Emanuele
    Meola, Giovanni
    Cardani, Rosanna
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [26] Side effects of anesthesia in DM2 as compared to DM1: a comparative retrospective study
    Kirzinger, L.
    Schmidt, A.
    Kornblum, C.
    Schneider-Gold, C.
    Kress, W.
    Schoser, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (06) : 842 - 845
  • [27] Altered Ca2+ Homeostasis and Endoplasmic Reticulum Stress in Myotonic Dystrophy Type 1 Muscle Cells
    Botta, Annalisa
    Malena, Adriana
    Loro, Emanuele
    Del Moro, Giulia
    Suman, Matteo
    Pantic, Boris
    Szabadkai, Gyorgy
    Vergani, Lodovica
    GENES, 2013, 4 (02): : 275 - 292
  • [28] Selective inhibition of MBNL1-CCUG interaction by small molecules toward potential therapeutic agents for myotonic dystrophy type 2 (DM2)†
    Wong, Chun-Ho
    Fu, Yuan
    Ramisetty, Sreenivasa Rao
    Baranger, Anne M.
    Zimmerman, Steven C.
    NUCLEIC ACIDS RESEARCH, 2011, 39 (20) : 8881 - 8890
  • [29] Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2
    Santoro, Massimo
    Masciullo, Marcella
    Bonvissuto, Davide
    Bianchi, Maria Laura Ester
    Michetti, Fabrizio
    Silvestri, Gabriella
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 380 (1-2) : 259 - 265
  • [30] Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1)
    Miele, Luca
    Perna, Alessia
    Dajko, Marianxhela
    Zocco, Maria A.
    De Magistris, Antonio
    Nicoletti, Tommaso F.
    Biolato, Marco
    Marrone, Giuseppe
    Liguori, Antonio
    Maccora, Daria
    Valenza, Venanzio
    Rossi, Salvatore
    Riso, Vittorio
    Di Natale, Daniele
    Gasbarrini, Antonio
    Grieco, Antonio
    Silvestri, Gabriella
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (11) : 1451 - 1457